Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 10, 2002, Pages 1056-1060

  Hernando, Monserrat ^a   González, Concepción ^a   Sánchez, Angel ^a   Guevara, Paloma ^a   Alejandro Navajo, José ^a   Papisch, Wolfgang ^a   González Buitrago, José Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Anti dsDNA antibodies; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; NUCLEIC ACID; PLASMID DNA;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOMATION; BINDING AFFINITY; CLINICAL LABORATORY; CLINICAL STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEVICE; DIABETES MELLITUS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; KIDNEY DISEASE; LIVER DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS HEPATITIS; AUTOANALYSIS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; FLUOROIMMUNOASSAY; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY;

ANTIBODIES, ANTINUCLEAR; AUTOANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROIMMUNOASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036431303     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.185     Document Type: Article

References (16)

1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1275.
3. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM. Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990; 33:634-43.
4. Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345:1595-9.
5. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare systemic lupus erythematosus: a prospective cohort study. Arthritis Rheum 1991; 34:937-44.
6. Esdaile JM, Abrahamowicz M, Josep L, McKenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: why some tests fail. Arthritis Rheum 1996; 39:370-8.
7. Okamura M, Kanayama Y, Amatsu K, Negoro N, Kohda S, Takeda T, et al. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis- correlation with severity of renal histology. Ann Rheum Dis 1993; 52:14-20.
8. Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Deicher H, et al. IgM anti-DNA antibodies in systemic lupus erythematosus: negative association with nephritis. Rheumatol Int 1998; 18:85-91.
9. Spronk PE, Limburg PC, Kallenberg CGM. Serological markers of disease activity in systemic lupus erythematosus. Lupus 1995; 4:86-94.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35:630-40.
11. Isenberg DA, Dudeney C, Williams W, Addison I, Charles S, Clarke J, et al. Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 1987; 44:448-56.
12. Smeenk RJ, van den Brink HG, Brinkman K, Termaat RM, Berden JH, Swaak AJ. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int 1991; 11:101-7.
13. Tipping PG, Buchanan RC, Riglar AG, Dimech WJ, Littlejohn GO, Holdsworth SR. Measurement of anti-dsDNA antibodies by ELISA: a comparative study with Crithidia and a Farr assay. Pathology 1991; 23:21-4.
14. Takeuchi Y, Ishikawa O, Miyachi Y. The comparative study of anti-double stranded DNA antibody levels measured by radioimmunoassay and enzyme-linked immunosorbent assay in systemic lupus erythematosus. J Dermatol 1997; 24:297-300.
15. Hermann J, Salmhofer W. A new fluorescence immunoassay as an alternative to the Farr assay for specific double-stranded DNA-antibody testing [abstract]. Lupus 2001; 10(Supp 1):S126.
16. Papisch W, Höpfl P, Zöllner Th. Comparison of different methods for detection of dsDNA antibodies. Evaluation of a new automated fluorescence immunoassay [abstract]. Lupus 2001; 10(Supp 1):S126.